Evidence map›Paper›PMID 31186245›Full record

Trial reportBMJ open2019

Community pharmacy lifestyle intervention to increase physical activity and improve cardiovascular health of men with prostate cancer: a phase II feasibility study.

Agnieszka Lemanska, Karen Poole, Bruce A Griffin, Ralph Manders, John M Saxton, Lauren Turner, Joe Wainwright, Sara Faithfull

Abstract readClinical Trial, Phase II
In one paragraph

Trial report in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. The role of community pharmacists in cancer survivorship care - a scoping review.Journal of cancer survivorship : research and practice · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Patient activation and patient-reported outcomes of men from a community pharmacy lifestyle intervention after prostate cancer treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Agnieszka LemanskaSchool of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.ORCID 0000-0003-4849-2430
Karen PooleSchool of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Bruce A GriffinDepartment of Nutritional Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Ralph MandersSchool of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
John M SaxtonDepartment of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, UK.
Lauren TurnerFrimley Health NHS Foundation Trust, Frimley, UK.
Joe WainwrightSurrey Human Performance Institute, University of Surrey, Guildford, UK.
Sara FaithfullSchool of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the feasibility and acceptability of a community pharmacy lifestyle intervention to improve physical activity and cardiovascular health of men with prostate cancer. To refine the intervention.

designPhase II feasibility study of a complex intervention.

settingNine community pharmacies in the UK.

interventionCommunity pharmacy teams were trained to deliver a health assessment including fitness, strength and anthropometric measures. A computer algorithm generated a personalised lifestyle prescription for a home-based programme accompanied by supporting resources. The health assessment was repeated 12 weeks later and support phone calls were provided at weeks 1 and 6.

participants116 men who completed treatment for prostate cancer. OUTCOME MEASURES: The feasibility and acceptability of the intervention and the delivery model were assessed by evaluating study processes (rate of participant recruitment, consent, retention and adverse events), by analysing delivery data and semi-structured interviews with participants and by focus groups with pharmacy teams. Physical activity (measured with accelerometry at baseline, 3 and 6 months) and patient reported outcomes (activation, dietary intake and quality of life) were evaluated. Change in physical activity was used to inform the sample size calculations for a future trial.

resultsOut of 403 invited men, 172 (43%) responded and 116 (29%) participated. Of these, 99 (85%) completed the intervention and 88 (76%) completed the 6-month follow-up (attrition 24%). Certain components of the intervention were feasible and acceptable (eg, community pharmacy delivery), while others were more challenging (eg, fitness assessment) and will be refined for future studies. By 3 months, moderate to vigorous physical activity increased on average by 34 min (95% CI 6 to 62, p=0.018), but this was not sustained over 6 months.

conclusionsThe community pharmacy intervention was feasible and acceptable. Results are encouraging and warrant a definitive trial to assess the effectiveness of the refined intervention.

Indexed as

ExerciseLife StylePhysical FitnessAgedAged, 80 and overAlgorithmsCommunity Pharmacy ServicesEnergy IntakeFeasibility StudiesFocus GroupsHealth PromotionHumansMaleMiddle AgedProstatic NeoplasmsQuality of Lifecommunity pharmacyfeasibilitylifestyle interventionphysical activityprostate cancersurvivorship

Identifiers

PMID31186245
PMCPMC6585832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.